ESMO World Congress on Gastrointestinal Cancer 2021

BRAF Mutant Allele Fraction May Predict Survival in Metastatic Colorectal Cancer

Publish Date July 19, 2021

When researchers combined clinical features with BRAF mutant allele fraction, patients could be divided into 3 risk groups that were significantly associated with survival.

Dose Capping May Explain Reduced Survival in Patients With Colorectal Cancer and High BMI

Publish Date July 16, 2021

The results suggest a link, but more research is needed.

Adding Nab-Paclitaxel to Gemcitabine May Improve Overall Survival in Resected Pancreatic Cancer

Publish Date July 15, 2021

Nab-paclitaxel was associated with an improvement in long-term overall survival.

Pembrolizumab Improves Upon Standard Care in Gastric, Gastroesophageal Junction Cancers

Publish Date July 14, 2021

The results led to another approved indication for pembrolizumab.

Antibiotic Use May Increase the Risk of Early-Onset Colon Cancer

Publish Date July 13, 2021

The association was observed with colon cancer but not rectal cancer.